|
ACVR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.439540E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.979430E-01 |
| Normal-vs-Stage2 |
5.744700E-03 |
| Normal-vs-Stage3 |
5.444300E-03 |
| Normal-vs-Stage4 |
5.469600E-02 |
| Stage1-vs-Stage2 |
6.487600E-02 |
| Stage1-vs-Stage3 |
4.706500E-02 |
| Stage1-vs-Stage4 |
2.784400E-01 |
| Stage2-vs-Stage3 |
7.874000E-01 |
| Stage2-vs-Stage4 |
4.867000E-01 |
| Stage3-vs-Stage4 |
6.003400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.603830E-02 |
| Normal-vs-AfricanAmerican |
1.260210E-01 |
| Normal-vs-Asian |
5.386000E-01 |
| Caucasian-vs-AfricanAmerican |
8.489200E-01 |
| Caucasian-vs-Asian |
8.290800E-01 |
| AfricanAmerican-vs-Asian |
8.095400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.039200E-03 |
| Normal-vs-Female |
4.877200E-01 |
| Male-vs-Female |
3.896400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.156300E-03 |
| Normal-vs-Age(41-60Yrs) |
5.296100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.329800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.004440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.125900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.345900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.370800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.806400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.285600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.691400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.220400E-01 |
| Normal-vs-Grade 2 |
1.059160E-01 |
| Normal-vs-Grade 3 |
1.969860E-02 |
| Normal-vs-Grade 4 |
5.279100E-03 |
| Grade 1-vs-Grade 2 |
9.936100E-02 |
| Grade 1-vs-Grade 3 |
6.597500E-02 |
| Grade 1-vs-Grade 4 |
4.276000E-02 |
| Grade 2-vs-Grade 3 |
2.802600E-01 |
| Grade 2-vs-Grade 4 |
9.207500E-02 |
| Grade 3-vs-Grade 4 |
3.867200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.328200E-01 |
| Normal-vs-ccB subtype |
5.063400E-03 |
| ccA subtype-vs-ccB subtype |
1.019670E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.396300E-02 |
| Normal-vs-N1 |
2.578600E-01 |
| N0-vs-N1 |
5.159800E-01 |
|
|
